These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 19244402

  • 21. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 22. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.
    Knoll T, Oltersdorf J, Göttmann U, Schaub M, Michel MS, Kirchengast M, van der Woude FJ, Rohmeiss P, Braun C.
    Transpl Int; 2003 Jun; 16(6):425-9. PubMed ID: 12819874
    [Abstract] [Full Text] [Related]

  • 23. Effects of spironolactone in an experimental model of chronic cyclosporine nephrotoxicity.
    Macunluoglu B, Arikan H, Atakan A, Tuglular S, Ulfer G, Cakalagaoglu F, Ozener C, Akoglu E.
    Transplant Proc; 2008 Jun; 40(1):273-8. PubMed ID: 18261605
    [Abstract] [Full Text] [Related]

  • 24. Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction.
    Vavrincova-Yaghi D, Deelman LE, van Goor H, Seelen MA, Vavrinec P, Kema IP, Gomolcak P, Benigni A, Henning RH, Sandovici M.
    Gene Ther; 2016 Nov; 23(11):797-806. PubMed ID: 27454318
    [Abstract] [Full Text] [Related]

  • 25. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity.
    Yilmaz S, Taskinen E, Paavonen T, Mennander A, Häyry P.
    Transpl Int; 1992 May; 5(2):85-95. PubMed ID: 1627245
    [Abstract] [Full Text] [Related]

  • 26. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 27. IF/TA-related metabolic changes--proteome analysis of rat renal allografts.
    Reuter S, Reiermann S, Wörner R, Schröter R, Edemir B, Buck F, Henning S, Peter-Katalinic J, Vollenbröker B, Amann K, Pavenstädt H, Schlatter E, Gabriëls G.
    Nephrol Dial Transplant; 2010 Aug; 25(8):2492-501. PubMed ID: 20176611
    [Abstract] [Full Text] [Related]

  • 28. Spironolactone in combination with cilazapril ameliorates proteinuria and renal interstitial fibrosis in rats with anti-Thy-1 irreversible nephritis.
    Asai M, Monkawa T, Marumo T, Fukuda S, Tsuji M, Yoshino J, Kawachi H, Shimizu F, Hayashi M, Saruta T.
    Hypertens Res; 2004 Dec; 27(12):971-8. PubMed ID: 15894838
    [Abstract] [Full Text] [Related]

  • 29. Renoprotective effects of long-term oral nicotine in a rat model of spontaneous proteinuria.
    Agarwal PK, van den Born J, van Goor H, Navis G, Gans RO, Bakker SJ.
    Am J Physiol Renal Physiol; 2012 Apr 01; 302(7):F895-904. PubMed ID: 22218593
    [Abstract] [Full Text] [Related]

  • 30. Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat.
    Leader CJ, Kelly DJ, Sammut IA, Wilkins GT, Walker RJ.
    Physiol Rep; 2020 May 01; 8(10):e14448. PubMed ID: 32441493
    [Abstract] [Full Text] [Related]

  • 31. The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial).
    Mortensen LA, Thiesson HC, Tougaard B, Egfjord M, Fischer ASL, Bistrup C.
    BMC Nephrol; 2018 May 03; 19(1):105. PubMed ID: 29724188
    [Abstract] [Full Text] [Related]

  • 32. HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms.
    Herrero-Fresneda I, Torras J, Franquesa M, Vidal A, Cruzado JM, Lloberas N, Fillat C, Grinyó JM.
    Kidney Int; 2006 Jul 03; 70(2):265-74. PubMed ID: 16710352
    [Abstract] [Full Text] [Related]

  • 33. Spironolactone in Post-Transplant Proteinuria: A Safe Alternative Therapy.
    de Sousa MV, Guida JP, do Valle CF, Camargo LF, Rivelli GG, Mazzali M.
    Transplant Proc; 2017 May 03; 49(4):813-816. PubMed ID: 28457401
    [Abstract] [Full Text] [Related]

  • 34. Beyond operational tolerance: effect of ischemic injury on development of chronic damage in renal grafts.
    Coulson MT, Jablonski P, Howden BO, Thomson NM, Stein AN.
    Transplantation; 2005 Aug 15; 80(3):353-61. PubMed ID: 16082331
    [Abstract] [Full Text] [Related]

  • 35. Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study.
    Ojeda-Cervantes M, Barrera-Chimal J, Alberú J, Pérez-Villalva R, Morales-Buenrostro LE, Bobadilla NA.
    Am J Nephrol; 2013 Aug 15; 37(5):481-90. PubMed ID: 23635604
    [Abstract] [Full Text] [Related]

  • 36. Adeno-associated viral vector-mediated interleukin-10 prolongs allograft survival in a rat kidney transplantation model.
    Chen B, Kapturczak MH, Joseph R, George JF, Campbell-Thompson M, Wasserfall CH, Atkinson MA, Tisher CC, Flotte TR, Agarwal A, Chen S.
    Am J Transplant; 2007 May 15; 7(5):1112-20. PubMed ID: 17456199
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term dietary L-arginine supplementation attenuates proteinuria and focal glomerulosclerosis in experimental chronic renal transplant failure.
    Albrecht EW, van Goor H, Smit-van Oosten A, Stegeman CA.
    Nitric Oxide; 2003 Feb 15; 8(1):53-8. PubMed ID: 12586542
    [Abstract] [Full Text] [Related]

  • 39. A reproducible model of chronic rejection in rat renal allografts.
    Jablonski P, Baxter K, Howden BO, Thomas AC, Marshall VC, Stein-Oakley A, Thomson NM.
    Aust N Z J Surg; 1995 Feb 15; 65(2):114-9. PubMed ID: 7857223
    [Abstract] [Full Text] [Related]

  • 40. Development of injury in a rat model of chronic renal allograft rejection: effect of dietary protein restriction.
    Bombas A, Stein-Oakley AN, Baxter K, Thomson NM, Jablonski P.
    Transpl Int; 1999 Feb 15; 12(1):18-26. PubMed ID: 10080402
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.